Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Thiophenes"" wg kryterium: Temat


Tytuł:
[New oral anticoagulants are as safe in elderly patients as conventional drugs].
Autorzy:
Steurer J; Horten-Zentrum für praxisorientierte Forschung und Wissenstransfer; Universitätsspital Zürich.
Pokaż więcej
Transliterated Title:
Neue orale Antikoagulanzien sind bei älteren Menschen so sicher wie die Herkömmlichen.
Źródło:
Praxis [Praxis (Bern 1994)] 2014 Aug 20; Vol. 103 (17), pp. 1032.
Typ publikacji:
Journal Article
MeSH Terms:
Anticoagulants/*therapeutic use
Benzimidazoles/*therapeutic use
Morpholines/*therapeutic use
Pyrazoles/*therapeutic use
Pyridones/*therapeutic use
Stroke/*prevention & control
Thiophenes/*therapeutic use
Thromboembolism/*prevention & control
beta-Alanine/*analogs & derivatives
Administration, Oral ; Age Factors ; Aged ; Anticoagulants/adverse effects ; Benzimidazoles/adverse effects ; Dabigatran ; Hemorrhage/chemically induced ; Hemorrhage/prevention & control ; Humans ; Morpholines/adverse effects ; Pyrazoles/adverse effects ; Pyridones/adverse effects ; Randomized Controlled Trials as Topic ; Rivaroxaban ; Thiophenes/adverse effects ; Treatment Outcome ; beta-Alanine/adverse effects ; beta-Alanine/therapeutic use
Czasopismo naukowe
Tytuł:
Angioedema due to the new oral anticoagulant rivaroxaban.
Autorzy:
Altin C; Department of Cardiology, Faculty of Medicine, University of Baskent, İzmir, Turkey.
Ozturkeri OA
Gezmis E
Askin U
Pokaż więcej
Źródło:
Annals of cardiac anaesthesia [Ann Card Anaesth] 2014 Apr-Jun; Vol. 17 (2), pp. 173-4.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Angioedema/*chemically induced
Anticoagulants/*adverse effects
Drug Hypersensitivity/*therapy
Morpholines/*adverse effects
Thiophenes/*adverse effects
Aged ; Angioedema/physiopathology ; Angioedema/therapy ; Anticoagulants/therapeutic use ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Electrocardiography ; Female ; Humans ; Morpholines/therapeutic use ; Rivaroxaban ; Thiophenes/therapeutic use
Raport
Tytuł:
Absence of both MDR1 (ABCB1) and breast cancer resistance protein (ABCG2) transporters significantly alters rivaroxaban disposition and central nervous system entry.
Autorzy:
Gong IY; Division of Clinical Pharmacology, University of Western Ontario, London, ON, Canada.
Mansell SE
Kim RB
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2013 Mar; Vol. 112 (3), pp. 164-70. Date of Electronic Publication: 2012 Oct 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
ATP Binding Cassette Transporter, Subfamily B, Member 1/*antagonists & inhibitors
ATP-Binding Cassette Transporters/*antagonists & inhibitors
Anticoagulants/*pharmacokinetics
Central Nervous System/*metabolism
Morpholines/*pharmacokinetics
Thiophenes/*pharmacokinetics
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; ATP Binding Cassette Transporter, Subfamily G, Member 2 ; ATP-Binding Cassette Transporters/genetics ; Administration, Oral ; Animals ; Anticoagulants/administration & dosage ; Anticoagulants/blood ; Caco-2 Cells ; Cell Membrane Permeability/drug effects ; Humans ; Male ; Metabolic Clearance Rate ; Mice ; Mice, Knockout ; Morpholines/administration & dosage ; Morpholines/blood ; Rivaroxaban ; Substrate Specificity ; Thiophenes/administration & dosage ; Thiophenes/blood ; Tissue Distribution
Czasopismo naukowe
Tytuł:
A case report describing a suspected rivaroxaban hypersensitivity reaction in a surgical patient.
Autorzy:
Yates J; Department of Orthopaedics, Macclesfield District General Hospital, East Cheshire NHS Trust, Macclesfield, UK. />Choudhry M
Keys G
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2013 Apr; Vol. 38 (2), pp. 159-61. Date of Electronic Publication: 2012 Nov 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Anticoagulants/*adverse effects
Drug Hypersensitivity/*etiology
Morpholines/*adverse effects
Thiophenes/*adverse effects
Anticoagulants/therapeutic use ; Arthroplasty, Replacement, Knee ; Humans ; Male ; Middle Aged ; Morpholines/therapeutic use ; Rivaroxaban ; Thiophenes/therapeutic use
Czasopismo naukowe
Tytuł:
Pharmacodynamic and pharmacokinetic basics of rivaroxaban.
Autorzy:
Kreutz R; Department of Clinical Pharmacology and Toxicology, Charité- Universitätsmedizin, Charitéplatz 1, Berlin, Germany.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2012 Feb; Vol. 26 (1), pp. 27-32. Date of Electronic Publication: 2011 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Anticoagulants/*pharmacology
Morpholines/*pharmacology
Thiophenes/*pharmacology
Venous Thromboembolism/*prevention & control
Administration, Oral ; Adult ; Age Factors ; Anticoagulants/pharmacokinetics ; Arthroplasty, Replacement, Hip/adverse effects ; Arthroplasty, Replacement, Hip/methods ; Arthroplasty, Replacement, Knee/adverse effects ; Arthroplasty, Replacement, Knee/methods ; Biological Availability ; Dose-Response Relationship, Drug ; Drug Interactions ; Female ; Half-Life ; Humans ; Male ; Morpholines/administration & dosage ; Morpholines/pharmacokinetics ; Rivaroxaban ; Thiophenes/administration & dosage ; Thiophenes/pharmacokinetics ; Venous Thromboembolism/etiology
Czasopismo naukowe
Tytuł:
A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting.
Autorzy:
Zindel S; Institute of Health Economics and Clinical Epidemiology of the University of Cologne, Gleueler Strasse 176-178, 50935, Cologne, Germany.
Stock S
Müller D
Stollenwerk B
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2012 Jul 09; Vol. 12, pp. 192. Date of Electronic Publication: 2012 Jul 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthroplasty, Replacement, Hip*
Arthroplasty, Replacement, Knee*
Anticoagulants/*economics
Enoxaparin/*economics
Morpholines/*economics
Postoperative Complications/*prevention & control
Thiophenes/*economics
Venous Thromboembolism/*prevention & control
Anticoagulants/therapeutic use ; Cost-Benefit Analysis ; Databases, Factual ; Decision Trees ; Enoxaparin/therapeutic use ; Germany ; Humans ; Morpholines/therapeutic use ; Multicenter Studies as Topic ; National Health Programs ; Randomized Controlled Trials as Topic ; Rivaroxaban ; Thiophenes/therapeutic use
Czasopismo naukowe
Tytuł:
[The new Anticoagulants - Relevant Facts for the GP].
Autorzy:
Asmis LM; Unilabs Gerinnungslabor Zürich und Zentrum für perioperative Thrombose und Hämostase, Zürich.
Pokaż więcej
Transliterated Title:
Die neuen Antikoagulantien - Was muss der Praktiker wissen?
Źródło:
Praxis [Praxis (Bern 1994)] 2011 Aug 10; Vol. 100 (16), pp. 971-6.
Typ publikacji:
Comparative Study; English Abstract; Journal Article; Review
MeSH Terms:
Factor Xa Inhibitors*
Anticoagulants/*therapeutic use
Antithrombins/*therapeutic use
Benzimidazoles/*therapeutic use
Morpholines/*therapeutic use
Pyrazoles/*therapeutic use
Pyridones/*therapeutic use
Thiophenes/*therapeutic use
Venous Thromboembolism/*prevention & control
beta-Alanine/*analogs & derivatives
Anticoagulants/adverse effects ; Anticoagulants/pharmacology ; Antithrombins/adverse effects ; Antithrombins/pharmacokinetics ; Atrial Fibrillation/blood ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Benzimidazoles/adverse effects ; Benzimidazoles/pharmacokinetics ; Biological Availability ; Clinical Trials, Phase III as Topic ; Dabigatran ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Evidence-Based Medicine ; General Practice ; Humans ; Metabolic Clearance Rate/physiology ; Morpholines/adverse effects ; Morpholines/pharmacokinetics ; Pyrazoles/adverse effects ; Pyrazoles/pharmacokinetics ; Pyridones/adverse effects ; Pyridones/pharmacokinetics ; Rivaroxaban ; Thiophenes/adverse effects ; Thiophenes/pharmacokinetics ; Venous Thromboembolism/blood ; beta-Alanine/adverse effects ; beta-Alanine/pharmacokinetics ; beta-Alanine/therapeutic use
Czasopismo naukowe
Tytuł:
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.
Autorzy:
Perzborn E; Global Therapeutic Research, Pharma R&D, Bayer HealthCare, Wuppertal, Germany. />Roehrig S
Straub A
Kubitza D
Misselwitz F
Pokaż więcej
Źródło:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2011 Jan; Vol. 10 (1), pp. 61-75. Date of Electronic Publication: 2010 Dec 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Drug Design*
Anticoagulants/*pharmacology
Morpholines/*pharmacology
Thiophenes/*pharmacology
Administration, Oral ; Animals ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Clinical Trials as Topic ; Drug Delivery Systems ; Drug Evaluation, Preclinical ; Factor Xa Inhibitors ; Humans ; Morpholines/administration & dosage ; Morpholines/adverse effects ; Rivaroxaban ; Structure-Activity Relationship ; Thiophenes/administration & dosage ; Thiophenes/adverse effects
Czasopismo naukowe
Tytuł:
Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials.
Autorzy:
Trkulja V; Department of Pharmacology, Zagreb University School of Medicine, Salata 11, 10000 Zagreb, Croatia. />Kolundzic R
Pokaż więcej
Źródło:
Croatian medical journal [Croat Med J] 2010 Apr; Vol. 51 (2), pp. 113-23.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Review
MeSH Terms:
Arthroplasty, Replacement, Hip*/adverse effects
Arthroplasty, Replacement, Knee*/adverse effects
Anticoagulants/*therapeutic use
Benzimidazoles/*therapeutic use
Morpholines/*therapeutic use
Pyridines/*therapeutic use
Thiophenes/*therapeutic use
Venous Thromboembolism/*prevention & control
Anticoagulants/adverse effects ; Benzimidazoles/adverse effects ; Dabigatran ; Enoxaparin/adverse effects ; Enoxaparin/therapeutic use ; Hemorrhage/chemically induced ; Humans ; Morpholines/adverse effects ; Postoperative Care ; Pyridines/adverse effects ; Randomized Controlled Trials as Topic ; Rivaroxaban ; Safety ; Survival Analysis ; Thiophenes/adverse effects ; Venous Thromboembolism/etiology
Czasopismo naukowe
Tytuł:
Use of Thromboelastography (TEG) for Detection of New Oral Anticoagulants.
Autorzy:
Dias JD; From Clinical Marketing, Haemonetics SA, Signy, Switzerland (Dr Dias); Operations Department (Ms Norem) and Scientific Research & Biomedical (Dr Doorneweerd), Haemonetics Corporation, Rosemont, and Medical Affairs, Haemonetics Corporation, Chicago (Dr Omert), Illinois; Hospital Division (Dr Thurer) and Medical Affairs (Dr Popovsky), Haemonetics Corporation, Braintree, Massachusetts; and Department of Surgery, Einstein Medical Center, Philadelphia, Pennsylvania (Dr Omert). Dr Omert is now with Acquired Bleeding, CSL Behring, King of Prussia, Pennsylvania.
Norem K
Doorneweerd DD
Thurer RL
Popovsky MA
Omert LA
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2015 May; Vol. 139 (5), pp. 665-73.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anticoagulants/*blood
Antithrombins/*blood
Factor Xa Inhibitors/*blood
Thrombelastography/*methods
Venous Thromboembolism/*drug therapy
Adolescent ; Anticoagulants/administration & dosage ; Antithrombins/administration & dosage ; Benzimidazoles/administration & dosage ; Benzimidazoles/blood ; Dabigatran ; Factor Xa Inhibitors/administration & dosage ; Humans ; Morpholines/administration & dosage ; Morpholines/blood ; Pyrazoles/administration & dosage ; Pyrazoles/blood ; Pyridones/administration & dosage ; Pyridones/blood ; Rivaroxaban ; Sensitivity and Specificity ; Thiophenes/administration & dosage ; Thiophenes/blood ; Venous Thromboembolism/prevention & control ; Young Adult ; beta-Alanine/administration & dosage ; beta-Alanine/analogs & derivatives ; beta-Alanine/blood
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies